5 Best Shipping Stocks To Own For 2014

Microsoft (NASDAQ: MSFT  ) and Google (NASDAQ: GOOG  ) messed up, and in a few months they may start paying the price. When Microsoft's Xbox One fails to gain traction the way its current video-game console did -- and when the high-tech Google Glass specs falter at the retail level -- there will be no shortage of scapegoats.

Microsoft angered gamers with restrictive policies, and that sentiment's going to stick even if the restrictions did not. Google Glass probably hit the market at too high a price for the first wave of wearable computing products. Xbox One priced itself for too much more than the rival PS4 and Wii U platforms. Google Glass was overrun by early-adopter hipsters that few would want to emulate.

All of this can be remedied. Microsoft can be more generous. Both companies have the financial flexibility to slash prices aggressively. Shipping out Google Glass to a few dozen celebrity tastemakers would turn momentum back toward mainstream appeal.

5 Best Managed Healthcare Stocks To Own Right Now: Sharp Corp (SRP)

Sharp Corporation is a Japan-based company mainly engaged in the manufacture and sale of electric telecommunication, electric and electronic equipment. The Company operates in two business segments. The Electronics Equipment segment offers audio and video (AV) and communication products, including liquid crystal color televisions, projectors and various telephones; health and environmental equipment, including refrigerators, microwaves and air conditioners, as well as information equipment, such as handy terminal equipment, electronic registers, information displays and copy machines. The Electronic Component segment provides liquid related products such as liquid crystal display modules, solar cells, as well as other electronic devices, such as parts for satellite broadcasting, regulators and optical sensors. The Company withdrawed from solar battery production in United Kingdom by end of Feb. 2014. Advisors' Opinion:

• [By Alexis Xydias]

  Eurasian Natural Resources Corp. fell 3.7 percent, as a gauge of London-listed commodity producers dropped. BAE Systems Plc (BA/) retreated 2.1 percent after Deutsche Bank AG downgraded Europe�� biggest defense company. Serco Group Plc (SRP) advanced 2.7 percent after saying first-half sales will grow at a faster pace than it had estimated.

• [By Sofia Horta e Costa]

  Vivendi SA climbed 2.7 percent after posting better-than-estimated third-quarter profit and saying it plans to spin off its French phone carrier SFR by July 2014. Serco Group Plc (SRP) increased 1.7 percent as UBS AG upgraded the stock. Safran SA (SAF) lost 3.2 percent as its largest shareholder sold a stake.

5 Best Shipping Stocks To Own For 2014: PIMCO Global StocksPLUS & Income Fund (PGP)

PIMCO Global StocksPLUS & Income Fund (the Fund) is a non-diversified, closed-end management investment company. The Fund invests in equity index derivative instruments relating to United States and non-United States markets, backed by a low-duration (1 to 3 year) debt portfolio with an average credit quality that is investment grade. The Fund's investment manager is Allianz Global Investors Fund Management LLC, which is an indirect wholly owned subsidiary of Allianz Global.

The Fund intends to gain substantially all of its equity index exposure by investing in equity index derivatives based on the Standard & Poor's 500 Composite Stock Price Index (S&P 500 Index), and the Morgan Stanley Capital International Europe, Australasia, Far East Index (the MSCI EAFE Index). Substantially all of the Fund's assets will be invested in a portfolio of income producing debt securities and debt-related derivative securities.

Advisors' Opinion:

• [By Robert Rapier]

  Note that the partnerships that have chosen to pay taxes as corporations are almost exclusively engaged in marine transportation. Outside of this category, the only publicly traded partnership that has chosen corporate taxation is Plains GP Holding (NYSE: PGP), the general partner for Plains All American Pipeline (NYSE: PAA).

5 Best Shipping Stocks To Own For 2014: ImmunoGen Inc.(IMGN)

ImmunoGen, Inc. engages in the research and development of targeted therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies, and highly potent cell-killing agents. The company develops its products using its Targeted Antibody Payload (TAP) technology. Its product candidates include Trastuzumab emtansine (T-DM1), a Phase III clinical trial product for HER2+ breast cancer; lorvotuzumab mertansine (IMGN901), a Phase I clinical trial product, which targets CD56 found on small-cell lung cancer, Merkel cell carcinoma, multiple myeloma, ovarian cancers, carcinoid tumors, and other cancers of neuroendocrine origin; IMGN529, a pre-investigational new drug stage drug for CD37+ B-cell malignancies, such as non-Hodgkin's lymphoma; and IMGN853, a preclinical stage product for cancers that overexpress folate receptor 1, including ovarian cancer. The company?s earlier-stage compounds in development stage comprise SAR3419, a Phase I clinical trial product for CD19+ B-cell malignancies, including non-Hodgkin's lymphoma; SAR650984, a Phase I clinical trial product for CD38+ hematological malignancies; SAR566658, a phase one clinical trial product for DS6+ solid tumors; and BT-062, a Phase I product for multiple myeloma. It has collaboration agreements with Amgen, Inc.; Bayer Schering Pharma AG; Biogen Idec MA Inc.; Biotest AG; Genentech, Inc.; Novartis Institutes for BioMedical Research, Inc.; and sanofi-aventis U.S. LLC. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:

• [By John Udovich]

  Cramer Talks Up Biotech and Cancer Biotech in Particular. For what his opinion might be worth, MSNBC�� Mad Money host Jim Cramer recently commented that the 25 best-performing small cap stocks this year are "almost entirely biotech." He went on to point out that Celldex Therapeutics has been "just incredible��and that other companies to watch include Celgene Corporation (NASDAQ: CELG), ImmunoGen, Inc (NASDAQ: IMGN) and Onyx Pharmaceuticals, Inc (NASDAQ: ONXX), which all have promising cancer products on the way. He also added that:�

• [By RichardCox]

  While it is important to seek out well-established companies with a proven product line, it should be remembered that it is still possible to find long-term opportunities in companies that are still in the clinical stage. In these cases, risk can be reduced by identifying those companies with a diversified set of drug innovations. So, when smaller companies are limited in the types of diseases and treatments, there is generally less protection from investment risk. One example of a smaller company with strong product positioning is ImmunoGen (IMGN).

• [By Sean Williams]

  Now what: We're still in the top of the second inning of a nine-inning game here, but ADCs certainly appear to be the future of cancer therapy -- at least one path to treating it. Immunomedics still has a long road to climb as its two ADC peers are much further along in their development process. ImmunoGen (NASDAQ: IMGN  ) , for instance, already has an FDA-approved drug for late-stage HER2-positive breast cancer known as Kadcyla that utilizes the company's proprietary targeted-antibody payload technology (the same concept as ADCs with a different name) in combination with Roche's�Herceptin. In trials, this combo extended median overall survival by 5.8 months over the placebo to 30.9 months. Something similar can be said for Seattle Genetics�and its ADC pipeline.

• [By Sean Williams]

  A moat of competition, but plenty of upside
  However, investors would probably be wise not to get too carried away with yesterday's news given that another therapy -- which I would certainly call revolutionary�-- known as Kadcyla for HER2-positive breast cancer was just approved in February. Kadcyla, developed by Roche�and ImmunoGen (NASDAQ: IMGN  ) piggybacks a toxin on an antibody and, using ImmunoGen's proprietary targeted antibody payload technology, delivers a higher dose of toxin directly to the targeted cancer, which has a signature protein that causes the release of the toxin from the antibody. In late-stage trials, Kadcyla improved PFS by 50% over the placebo to 9.6 months.

5 Best Shipping Stocks To Own For 2014: British American Tobacco PLC (BATS)

British American Tobacco p.l.c. (British American Tobacco) is a holding company. The Company�� four principal brands include Dunhill, Kent, Lucky Strike and Pall Mall. The Company has many other famous international and local brands, including Rothmans, Vogue, Viceroy, Kool, Peter Stuyvesant and Benson & Hedges. The Company�� brands are sold in over 180 markets. The Company�� products include Cigarettes, Smokeless snus and Cigars. The Company has over 44 cigarette factories in 39 countries. In addition to cigarettes, the Company makes cigarillos, roll your own and pipe tobacco. Advisors' Opinion:

• [By Namitha Jagadeesh]

  European stocks advanced for a fifth day, their longest rally this year, as data showed the U.K. avoided a triple-dip recession and as companies including British American Tobacco Plc (BATS) reported results.